Does increased CCL2-mediated immune cell recruitment during mucosal BCG vaccination provide superior protection against TB?

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	3763-3764
Number of pages	2
Journal	Molecular Therapy
Volume	32
Issue number	11
DOIs	https://doi.org/10.1016/j.ymthe.2024.10.009
State	Published - Nov 6 2024

Access to Document

10.1016/j.ymthe.2024.10.009

Other files and links

Link to publication in Scopus

Cite this

@article{8b33da9dcefe426f94407752993132ad,

title = "Does increased CCL2-mediated immune cell recruitment during mucosal BCG vaccination provide superior protection against TB?",

author = "Gregory Serpa and Hemann, \{Emily A.\} and Long, \{Matthew E.\}",

year = "2024",

month = nov,

day = "6",

doi = "10.1016/j.ymthe.2024.10.009",

language = "English",

volume = "32",

pages = "3763--3764",

journal = "Molecular Therapy",

issn = "1525-0016",

number = "11",

}

TY - JOUR

T1 - Does increased CCL2-mediated immune cell recruitment during mucosal BCG vaccination provide superior protection against TB?

AU - Serpa, Gregory

AU - Hemann, Emily A.

AU - Long, Matthew E.

PY - 2024/11/6

Y1 - 2024/11/6

UR - https://www.scopus.com/pages/publications/85207350799

U2 - 10.1016/j.ymthe.2024.10.009

DO - 10.1016/j.ymthe.2024.10.009

M3 - Comment/debate

C2 - 39489905

AN - SCOPUS:85207350799

SN - 1525-0016

VL - 32

SP - 3763

EP - 3764

JO - Molecular Therapy

JF - Molecular Therapy

IS - 11

ER -